BEL vs SUNPHARMA: Stock Comparison
Sun Pharmaceutical Industries Ltd is the larger company by market capitalisation. Bharat Electronics Ltd shows a higher ROE, lower leverage and a higher ROCE, while Sun Pharmaceutical Industries Ltd shows a lower P/E, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
BEL leads 5; SUNPHARMA leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | BEL | SUNPHARMA |
|---|---|---|
| Sector | Capital Goods | Healthcare |
| Industry | Aerospace & Defense | Pharmaceuticals |
Price
| Metric | BEL | SUNPHARMA |
|---|---|---|
| Live Price | ₹405.7 | ₹1,944 |
| Day Change | -0.04% | 0.1% |
| Volume | 1.31 Cr | 15.36 L |
| 52-Week High | ₹473.45 | ₹2,046.9 |
| 52-Week Low | ₹361.2 | ₹1,548 |
| Distance from 52W High | -14.31% | -5.03% |
Valuation
| Metric | BEL | SUNPHARMA |
|---|---|---|
| Market Cap | ₹2.96 L Cr | ₹4.65 L Cr |
| P/E Ratio | 48.04x | 38.39x |
| P/B Ratio | 12.31x | 5.56x |
| EPS | ₹8.41 | ₹50.4 |
| Book Value | ₹32.82 | ₹348 |
| Dividend Yield | 0.62% | 0.82% |
Growth
| Metric | BEL | SUNPHARMA |
|---|---|---|
| Revenue Growth (TTM YoY) | 11.7% | 12.8% |
| EPS Growth (TTM YoY) | 4.5% | 25.6% |
| Qtr Sales Growth | 11.8% | 10.5% |
| Qtr Profit Growth | 4.62% | 5.95% |
Profitability & Leverage
| Metric | BEL | SUNPHARMA |
|---|---|---|
| ROE | 27.6% | 16% |
| ROCE | 36.5% | 20.5% |
| Net Margin | 22.29% | 18.56% |
| Operating Margin | 29.2% | 29.8% |
| Debt to Equity | 0x | 0.06x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | BEL | SUNPHARMA |
|---|---|---|
| Promoter Holding | 51.14% | 54.48% |
| FII Holding | 18.02%▼ 1.48 pp | 14.53%▼ 1.4 pp |
| DII Holding | 21.02%▲ 1.03 pp | 22.18%▲ 1.07 pp |
| Public Holding | 9.82%▲ 0.45 pp | 8.81%▲ 0.33 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Bharat Electronics Ltd and Sun Pharmaceutical Industries Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.